The U.S. biotechnology arena is undergoing a record-breaking M&A cycle for the industry. After generating M&A activity valued at $235 billion during 2014, the U.S. biotech sector produced more than $100 billion in deals during first-quarter 2015.

By John Kamp • Executive Director of the Coalition for Healthcare Communication So, you already know that the 300+ page bill which includes a broad array of amendments related to the National Institute of Health (NIH) and the Food and Drug Administration (FDA) passed out of the House Commerce Committee on May 21 by an […]

Changes at the top at Giant Steven Gold has been selected as CEO and Jeffrey Nemy has joined the company as chief financial officer. Gold, who is one of Giant’s co-founders, has served as an agency principal since its start 13 years ago. In the CEO role, Gold provides leadership and oversight to the company’s […]